MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE
批准号:
6612888
负责人:
Peter C. Melby
金额:
$18.83万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-30 至 2005-08-31
关键词:
antibody neutralization test antiserum bioassay cardiopulmonary disease chemokine complementary DNA cytokine disease /disorder model enzyme linked immunosorbent assay gene expression genetic library hamsters hybridomas infection inflammation laboratory mouse laboratory rabbit model design /development molecular cloning molecular pathology neoplasm /cancer polymerase chain reaction tissue /cell culture transfection /expression vector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Syrian hamster (Mesocricetus auratus) has unique features that make it advantageous for use as a model for a number of infectious, cardiopulmonary, inflammatory, and neoplastic diseases. Substantive work has been performed using the hamster to study these disease models, but investigations into the molecular nature of the disease processes have been hindered by the lack of available reagents. In particular, studs' of diseases in which the pathogenesis involves immunologic or inflammatory mechanisms has been severely limited. The overall objective of this proposed applied research is to develop molecular tools that will enable the further development of the hamster as a model of human infectious, cardiopulmonary, inflammatory, and neoplastic disease. Because of the hamster's genetic divergence from mice and rats, there are very few immunological reagents used for mouse and rat studies which can also be used in the study of hamster models of disease. In this proposed research we will clone and express several hamster cytokine and chemokine cDNAs which have been shown in humans and animal models to play a critical role in the regulation and effector activity of the host immune and inflammatory' responses. We will then develop anti-cytokine and antichemokine antibody reagents that can be used in these models to detect, quantify, and neutralize these molecules. The development of this core of immunological reagents specifically for the hamster will have broad application to the development of models of disease in this animal. This work will have particular relevance to research traditionally funded through a number of NIH institutes including the NCI, NIAID, NHLBI, NIA, NIAMS, and NIDR.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Biological activity of hamster interferon-gamma is modulated by the carboxyl-terminal tail.
仓鼠干扰素-γ的生物活性由羧基末端尾部调节。
DOI:
10.1016/j.cyto.2006.05.006
发表时间:
2006
期刊:
Cytokine.
影响因子:
--
作者:
[Zhao,Weiguo, Valencia,AnaisZ, Melby,PeterC]
通讯作者:
Melby,PeterC
Physician-Scientist Training in Emerging Infectious Diseases
-
批准号:10647762
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2021
-
负责人:Peter C. Melby
-
依托单位:
Physician-Scientist Training in Emerging Infectious Diseases
-
批准号:10270872
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2021
-
负责人:Peter C. Melby
-
依托单位:
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis
-
批准号:10062846
-
项目类别:
-
资助金额:$54.82万
-
财政年份:2017
-
负责人:Peter C. Melby
-
依托单位:
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis
-
批准号:10302274
-
项目类别:
-
资助金额:$54.82万
-
财政年份:2017
-
负责人:Peter C. Melby
-
依托单位:
Malnutrition-related Lymph Node Dysfunction and Risk of Visceral Leishmaniasis
-
批准号:8702843
-
项目类别:
-
资助金额:$23.24万
-
财政年份:2014
-
负责人:Peter C. Melby
-
依托单位:
Discovery of 4-aminoquinoline therapeutics for visceral leishmaniasis
-
批准号:8207443
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2010
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement
-
批准号:7758284
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2009
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement
-
批准号:7559198
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2009
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement
-
批准号:8012292
-
项目类别:
-
资助金额:$3.62万
-
财政年份:2009
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:7347521
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:7174817
-
项目类别:
-
资助金额:$29.51万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:7009285
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:6922649
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:7577390
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA
-
批准号:6258034
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2001
-
负责人:Peter C. Melby
-
依托单位:
VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA
-
批准号:6497391
-
项目类别:
-
资助金额:$31.31万
-
财政年份:2001
-
负责人:Peter C. Melby
-
依托单位:
VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA
-
批准号:6628085
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2001
-
负责人:Peter C. Melby
-
依托单位:
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE
-
批准号:6464011
-
项目类别:
-
资助金额:$1.38万
-
财政年份:2000
-
负责人:Peter C. Melby
-
依托单位:
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE
-
批准号:6529843
-
项目类别:
-
资助金额:$24.21万
-
财政年份:2000
-
负责人:Peter C. Melby
-
依托单位:
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE
-
批准号:6129514
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2000
-
负责人:Peter C. Melby
-
依托单位:
海外基金